SciCombinator

Discover the most talked about and latest scientific content & concepts.

Concept: Central retinal vein

28

: To investigate the effect that panretinal photocoagulation to peripheral areas of retinal vascular nonperfusion has on the visual acuity and injection frequency of ranibizumab in eyes with previous central retinal vein occlusion.

Concepts: Retina, Visual acuity, Central retinal vein, Central retinal vein occlusion

27

To evaluate the efficacy, safety, and reinjection interval of dexamethasone intravitreal implant (DEX implant) in branch retinal vein occlusion and central retinal vein occlusion patients receiving ≥2 DEX implant treatments.

Concepts: Dexamethasone, Central retinal vein, Central retinal vein occlusion

0

To assess and compare the efficacy over 6 months of intravitreal ranibizumab (IR), aflibercept (IA) and dexamethasone implant (IDI) in eyes with macular edema (ME) secondary to non-ischemic central retinal vein occlusion (CRVO).

Concepts: Macular degeneration, Central retinal vein, Central retinal vein occlusion

0

To understand the relationship between baseline ischemic index (IsI) values on ultra-widefield fluorescein angiography and classification as ischemic central retinal vein occlusion (CRVO).

Concepts: Fluorescein, Central retinal vein

0

To compare functional and anatomic outcomes of treatment with intravitreal aflibercept versus bevacizumab and/or ranibizumab in patients with recurrent macular edema (ME) secondary to central retinal vein occlusion (CRVO).

Concepts: Macular degeneration, Central retinal vein, Central retinal vein occlusion

0

To investigate the therapeutic potential of YC-1 for experimental central retinal vein occlusion (CRVO) of rhesus monkey.

Concepts: Primate, Rhesus Macaque, Monkeys in space, Central retinal vein

0

To evaluate the therapeutic outcome for dexamethasone implant (DEX) or intravitreal ranibizumab (IVR) injections over 6 months in patients with macular edema due to branch or central retinal vein occlusion (BRVO, CRVO), in a real-life setting.

Concepts: Clinical trial, Macular degeneration, Dexamethasone, Central retinal vein, Central retinal vein occlusion

0

A 15-year-old healthy boy developed acute, rapidly progressing visual loss in left eye following herpes zoster dermatitis, with a combined central retinal artery occlusion (CRAO) and central retinal vein occlusion (CRVO), along with optic perineuritis. Laboratory tests were negative. Despite an empirical, intensive antiviral treatment with systemic corticosteroids, and vision could not be restored in the affected eye. Herpes zoster dermatitis, in an immunocompetent individual, may be associated with a combined CRAO and CRVO along with optic perineuritis, leading to profound visual loss.

Concepts: Corticosteroid, Retina, Visual perception, Systemic lupus erythematosus, Central retinal artery, Central retinal vein, Ophthalmic artery

0

To determine whether testosterone supplementation is associated with retinal artery occlusion (RAO) or retinal vein occlusion (RVO).

Concepts: Testosterone, Retina, Central retinal artery, Central retinal vein

0

To compare the safety, efficacy, and frequency of intravitreal injection of aflibercept and bevacizumab for treatment of macular edema secondary to central retinal vein occlusion.

Concepts: Central retinal vein, Central retinal vein occlusion